Markets:

Overview

News

Currencies

International

Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.470 +0.090 (+0.96%)

Streaming Delayed Price Updated: 12:19 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Earnings Preview: Prothena Corp ↗

November 02, 2022

Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp...

Via Benzinga

As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside ↗

October 28, 2022

In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The...

Via Benzinga

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

October 27, 2022

From Prothena Corporation plc

Via GlobeNewswire

Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients

October 20, 2022

Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which...

Via FinancialNewsMedia

Recap: Prothena Corp Q2 Earnings ↗

August 08, 2022

Prothena Corp (NASDAQ:PRTA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs ↗

March 16, 2022

Prothena Corporation plc (NASDAQ: PRTA)

Via Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 28, 2022

Gainers

Via Benzinga

LVWR Stock Alert: 7 Things to Know as LiveWire Starts Trading ↗

September 28, 2022

LiveWire (LVWR) stock is in the news Wednesday as the electric motorcycle company makes its trading debut today after a SPAC merger.

Via InvestorPlace

Why Is Prothena (PRTA) Stock Up 75% Today? ↗

September 28, 2022

Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company.

Via InvestorPlace

Stocks Take Another Stab At Rebound As Bond Yields Soften ↗

September 28, 2022

Stocks are making another attempt to rebound on Wednesday, with the Dow Jones Industrial Average and S&P 500 Index both up roughly 1% at the midway mark.

Via Talk Markets

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

How Is The Market Feeling About Prothena Corp? ↗

September 28, 2022

Prothena Corp's (NASDAQ:PRTA) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 2.46 million shares sold short, which is 13.83% of all regular...

Via Benzinga

US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗

September 28, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022 ↗

September 28, 2022

Upgrades

Via Benzinga

What's Going On With Prothena Stock Up Over 60% Today ↗

September 28, 2022

Prothena Corporation PLC (NASDAQ: PRTA) shares are trading higher by 61.27% to $49.88 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 28, 2022

Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

Via InvestorPlace

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

September 28, 2022

U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session.

Via Benzinga

Prothena Corp's Return On Capital Employed Overview ↗

August 31, 2022

Prothena Corp (NASDAQ:PRTA) brought in sales totaling $1.31 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 13.65%, resulting in a loss of $41.24 million.

Via Benzinga

Jim Cramer Says This Company Is A Great One ↗

June 16, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield.

Via Benzinga

Earnings Scheduled For August 8, 2022 ↗

August 08, 2022

Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Preview Of Prothena Corp's Earnings ↗

May 04, 2022

Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp...

Via Benzinga

Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock ↗

May 02, 2022

RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

May 02, 2022

Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading.

Via Benzinga

Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease ↗

April 26, 2022

Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

All News about Prothena Corporation plc - Ordinary Shares

Starting at $3.75/week.

Subscribe Today